anti-obesity

Pfizer Nears $7.3B Purchase of Anti-Obesity Drugmaker Metsera

https://invezz.com/news/2025/09/22/pfizer-close-to-acquiring-metsera-for-7-3b-targeting-breakthrough-obesity-drug/ Pfizer nears $7.3B deal to acquire Metsera, targeting next-gen obesity treatments. MET-097i shows 11.3% weight loss in trials and offers monthly dosing. Acquisition positions Pfizer against Novo Nordisk and Eli Lilly in obesity market. Pfizer is making a bold move in the pharmaceutical world by closing in on a $7.3 billion deal to acquire …

READ MORE

Bank of America expects 48 million US patients on anti-obesity medications by 2030.

It should be interesting to see how the consumer sector is impacted by this trend. In an inflationary environment with more focus on health, spending will shift. Another long-term trend that is worth watching. Follow us @KobeissiLetter for real time analysis as this develops. — The Kobeissi Letter (@KobeissiLetter) October 11, 2023 Why is there …

READ MORE

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads and the generous support of readers like you to keep delivering free, high-quality content. Right now, we are facing serious funding challenges and we need your help more than ever. Disable your ad blocker and this message will vanish. You can also sign up for a membership to enjoy an ad-free experience while supporting our work: https://citizenwatchreport.com/plans/subscriptions/ Your support helps us stay independent, continue our work, and keep content free for everyone. We truly appreciate your understanding and thank you for standing with us.